These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 11898726

  • 1. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM, Tulenov MT, Belokopit IN.
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [Abstract] [Full Text] [Related]

  • 2. [Our initial experience in using allapinin in patients with paroxysmal supraventricular tachycardias].
    Golitsyn SP, Sokolov SF, Alikhanov GN, Malakhov VI, Smetnev AS.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):94-7. PubMed ID: 2604894
    [Abstract] [Full Text] [Related]

  • 3. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
    O'Brien JF, Tremml GP, Falk JL.
    Am J Emerg Med; 1996 Jan; 14(1):50-2. PubMed ID: 8630157
    [Abstract] [Full Text] [Related]

  • 4. [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents].
    Hösl P, Rust M, Johannigmann J, Schmidt G.
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):313-6. PubMed ID: 8766489
    [Abstract] [Full Text] [Related]

  • 5. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
    Fomina IG, Iankin VV.
    Klin Med (Mosk); 1992 Jan; 70(1):26-32. PubMed ID: 1608203
    [Abstract] [Full Text] [Related]

  • 6. [Study of the comparative anti-arrhythmic effectiveness of allapinin, ethacizine and mexitil in patients with ventricular disorders of cardiac rhythm].
    Smetnev AS, Golitsyn SP, Levin ER, Sokolov SF, Koltunova MI.
    Ter Arkh; 1988 Jan; 60(8):34-8. PubMed ID: 3067410
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Jan; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 8. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
    Chachua T, Abuladze G, Nebieridze M.
    Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
    [Abstract] [Full Text] [Related]

  • 9. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P, Bernabò D, Faraguti SA.
    Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158
    [Abstract] [Full Text] [Related]

  • 10. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C, Busi G.
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [Abstract] [Full Text] [Related]

  • 11. Treatment of paroxysmal supraventricular tachycardia with adenosine: implications for nursing.
    Severson AL, Meyer LT.
    Heart Lung; 1992 Apr; 21(4):350-6. PubMed ID: 1629004
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N, Penev A, Kaponov Kh.
    Vutr Boles; 1984 Apr; 23(1):63-9. PubMed ID: 6730453
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population.
    Seet CM.
    Singapore Med J; 1997 Dec; 38(12):525-8. PubMed ID: 9550919
    [Abstract] [Full Text] [Related]

  • 14. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM, Olesin AI.
    Ter Arkh; 1996 Dec; 68(5):57-60. PubMed ID: 9082603
    [Abstract] [Full Text] [Related]

  • 15. [Verapamil in the treatment of paroxysmal supraventricular arrhythmia].
    Nartowicz E, Burduk P, Ukleja-Adamowicz M, Orzałkiewicz Z, Kłobukowski A.
    Kardiol Pol; 1987 Dec; 30 Suppl():92-6. PubMed ID: 3331404
    [No Abstract] [Full Text] [Related]

  • 16. [Amiodarone-induced hyperthyroidism causing progression of arrhythmia].
    Pintér A, Zámolyi K, Székely A, Préda I.
    Orv Hetil; 1994 Jul 10; 135(28):1535-8. PubMed ID: 8058296
    [Abstract] [Full Text] [Related]

  • 17. Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia.
    Dai GZ, Zeng B, Zhang YL, Lu YX.
    Chin Med J (Engl); 1990 Jun 10; 103(6):460-3. PubMed ID: 2119958
    [Abstract] [Full Text] [Related]

  • 18. [Criteria for a pathogenetic approach to antiarrhythmic therapy in paroxysmal supraventricular reciprocal tachycardia].
    Chireĭkin LV, Shubik IuV, Tiunin MI.
    Kardiologiia; 1990 Jun 10; 30(6):55-9. PubMed ID: 2214533
    [Abstract] [Full Text] [Related]

  • 19. Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia.
    Mason BA, Ricci-Goodman J, Koos BJ.
    Obstet Gynecol; 1992 Sep 10; 80(3 Pt 2):478-80. PubMed ID: 1495712
    [Abstract] [Full Text] [Related]

  • 20. [Use of digoxin in patients with paroxysmal supraventricular tachycardia].
    Smetnev AS, Titov VN, Shevchenko NM, Gurevich EM.
    Kardiologiia; 1989 Apr 10; 29(4):61-4. PubMed ID: 2666709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.